Mode
Text Size
Log in / Sign up

Meta-analysis of oxidative stress markers in oral leukoplakia versus healthy controls

Meta-analysis of oxidative stress markers in oral leukoplakia versus healthy controls
Photo by CDC / Unsplash
Key Takeaway
Note higher MDA in oral leukoplakia; evidence limited by inconsistency.

This systematic review and meta-analysis evaluated oxidative stress markers in patients with oral leukoplakia compared to healthy controls. Data were synthesized from 12 studies included in the analysis. The primary outcome assessed the status of oxidative stress and antioxidant markers across the pooled cohort.

The analysis found that malondialdehyde (MDA) levels were higher in patients with oral leukoplakia compared to controls. The pooled mean difference was 0.26 (95% CI: 0.22 to 0.3, p < 0.05). No specific adverse events or tolerability data were reported for the intervention or exposure status.

The authors identified limitations including inconsistent previous studies on changes of various OS and antioxidant markers and a lack of systematic comparison and evaluation. Funding or conflicts of interest were not reported. The review suggests identifying potential biomarkers for early diagnosis but cautions against overstatement of diagnostic value without further evidence.

Practice relevance is limited to recognizing oxidative stress as intrinsically linked to the initiation and progression of carcinogenesis. Clinicians should note these associations but avoid inferring causation from the observed data.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ObjectiveOral leukoplakia (OLK) is a common possibly malignant condition of the oral cavity, oxidative stress (OS) are intrinsically linked to the initiation and progression of carcinogenesis. However, previous studies on the changes of various OS and antioxidant markers in patients with OLK and their diagnostic value have been inconsistent, and there is a lack of systematic comparison and evaluation. This study aims to systematically evaluate and compare the status of OS and antioxidant markers in patients with OLK versus healthy controls to identify potential biomarkers for early diagnosis.MethodsA comprehensive electronic search was conducted across PubMed, Embase, Web of Science, and the Cochrane Library to identify case–control studies investigating antioxidant and OS markers in OLK patients compared to healthy individuals from database inception to May 1, 2025.ResultsTwelve studies were selected for inclusion in this meta-analysis. The analysis focused on five pro-oxidant substances and antioxidant state markers. Our findings revealed that the level of malondialdehyde (MDA) higher in patient with OLK (MD: 0.26, 95% CI: 0.22 to 0.3, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.